# Dobutamine

## Gendobu inj 250mg/20mL

##### 

| Title              | Content                                                                                                                                                                                                                              |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IDOB2                                                                                                                                                                                                                                |
| Indications        | Short-term treatment of cardiac decompensation due to depressed contractility resulting from heart disease or cardiac surgery.                                                                                                       |
| Dosing             | Must be diluted before infusion. Recommended dosage: usually 2.5-10 mcg/kg/minute as IV infusion. Infusion rate > 20 mcg/kg/minute for hemodynamic improvement. In rare cases， doses up to 40 mcg/kg/minute have been administered. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                        |
| Contraindications  | Obstructive cardiomyopathy.                                                                                                                                                                                                          |
| Adverse Effects    | Tachycardia， nausea， non-specific chest pain & palpitation. Cardiovascular: Angina (1% to 3% )， Hypertension (7.5% )， Tachyarrhythmia (approximately 10% ) Neurologic: Headache (1% to 3% )                                      |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                        |

